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Ribosome profiling measures genome-wide translation dynamics at sub-codon resolution.
Cycloheximide (CHX), a widely used translation inhibitor to arrest ribosomes in these
experiments, has been shown to induce biases in yeast, questioning its use. However,
whether such biases are present in datasets of other organisms including humans is
unknown. Here we compare different CHX-treatment conditions in human cells and yeast in
parallel experiments using an optimized protocol. We find that human ribosomes are not
susceptible to conformational restrictions by CHX, nor does it distort gene-level measure-
ments of ribosome occupancy, measured decoding speed or the translational ramp. Fur-
thermore, CHX-induced codon-specific biases on ribosome occupancy are not detectable in
human cells or other model organisms. This shows that reported biases of CHX are species-
specific and that CHX does not affect the outcome of ribosome profiling experiments in most
settings. Our findings provide a solid framework to conduct and analyze ribosome profiling
experiments.
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Protein synthesis is a multilayered process involving a ple-thora of factors that need to be coordinated in response tocellular and environmental cues1. The ribosome, an intri-
cate macromolecular machine, is central to this process as it
translates the genetic information encoded in messenger RNA
(mRNA) into a peptide sequence2,3. Even though work from
many laboratories has provided detailed insights into the bio-
chemical and kinetic aspects of translation—often using model
substrates—technical limitations have long hampered our
understanding of its regulation at a global level.
The development of ribosome profiling, a high-throughput
method that enables the quantitative analysis of transcriptome-
wide translation by determining ribosome positioning at sub-
codon resolution4, has revolutionized the analysis of cellular
translation. Ribosome profiling has allowed the characterization
of core properties of translation5, factors governing translational
dynamics6–8, and the analysis of individual translation events9–13.
The method is based on deep sequencing of ribosome-protected
mRNA fragments (RPFs or footprints) that are protected from
nucleolytic degradation4,14. However, ribosome profiling studies
have reached different conclusions on, e.g., the identification of
ORFs in zebrafish9,10,15, the influence of wobble base-pairing on
elongation speed16,17, or the relationship between elongation
rates and tRNA abundance13,18.
These discrepancies are in part caused by adaptations to the ori-
ginal protocols to match the needs of individual laboratories4,10,19–22.
The differences include the methods of sample harvesting19,23,
nuclease digestion24, preparation of libraries by circularization or
dual linker ligation, and more4,9,22,25–27. These small but crucial
differences may change the representation of in vivo translational
dynamics making direct comparisons between datasets challenging.
When harvesting any sample, two key elements likely influence the
outcomes of ribosome profiling experiments: The procedure and
speed of harvesting, and the use of translation inhibitors. To faithfully
capture the in vivo conformation and positioning of translating
ribosomes, the time span between the onset of harvesting and flash-
freezing of samples is kept at a minimum to prevent ribosome run-
off23. A second failsafe against undesired elongation in vivo and in
the lysate, is the treatment with the translation inhibitor cyclohex-
imide (CHX) used since the beginning in yeast4 and mammalian
cells28. CHX is a small molecule that inhibits translation elongation
by binding to the ribosomal E-site29,30. Several studies, particularly in
Saccharomyces cerevisiae, have reported biases in response to CHX
treatment31–36. CHX appears to reversibly interact with ribosomes,
allowing them to move away from their initial position on mRNA33.
This movement depends on codon identity, therefore, altering the
outcomes of studies that require codon-level resolution for occupancy
and translation-speed measurements33. Furthermore, high con-
centrations of CHX inhibit elongation, but not initiation29 leading to
ribosome accumulation at the start codon following CHX pre-
treatment5.
Despite those concerns, the addition or omission of CHX has
not been systematically compared in experiments using stan-
dardized conditions to the best of our knowledge. Most analyses
compared published ribosome profiling experiments performed
by different laboratories or datasets that varied several conditions
simultaneously. Therefore, some conclusions on the effects of
translation inhibitors may be affected by parameters other than
CHX usage. Finally, the effect of CHX has been predominantly
studied in S. cerevisiae and we know little about its impact in
vertebrates and other model organisms.
Here, we perform a comprehensive analysis of the effect of CHX
on ribosome profiling libraries in human and yeast in parallel
experiments. We use a highly standardized and optimized protocol
that reduces ribosomal RNA (rRNA) contamination, narrows the
footprint distribution, and captures high numbers of ribosome
footprints in the dominant reading frame. We found that—if prop-
erly handled—the use of CHX does not distort ribosome profiling
libraries in human cells. The inhibitor does not affect the quantifi-
cation of global translation levels, codon-specific ribosome occupancy
or the translational ramp. Furthermore, human ribosomes are not
susceptible to conformational restrictions by CHX. Similarly, we
found that CHX-mediated biases related to rare codons are absent
from commonly studied model organisms including two yeast spe-
cies. These findings show that the effects of CHX are species-specific
and do not affect the measurements of translation dynamics in many
commonly used model organisms except for baker’s yeast. Finally,
our results emphasize that the standardization and reporting of
parameters beyond the use of CHX will be crucial to improve the
comparability of ribosome profiling experiments.
Results
Stronger digestion of the cell lysate improves footprint size
distribution and frame information. To comprehensively analyze
the effect of CHX on human cells, we focused on HEK 293T cells as a
well-established model in ribosome profiling. To directly compare
our findings to previously reported biases, we performed parallel
experiments in S. cerevisiae. Translating ribosomes protect mRNA
from nuclease digestion during ribosome profiling experiments,
giving rise to two distinct footprint sizes4,32. Libraries prepared from
footprints excised between ~18 and 32 nt exhibit a bimodal size
distribution that centers around 21 nt and 28 nt (in yeast)4,32 or 21 nt
and 30 nt (in mammalian cells)28,37. These discrete footprint sizes,
21–22 nt (short footprints) and 28–32 nt (long footprints), have been
attributed to distinct conformational states of translating
ribosomes32,37. If nuclease digestion is stringent, unprotected
nucleotides are efficiently trimmed leading to a characteristic three-
nucleotide periodicity of mapped reads4. The larger the fraction of
footprints that map to the correct reading-frame of the ORFs the
higher the confidence, with which ribosomal A-, P- and E-sites can
be assigned within the footprints. Therefore, we initiated our analysis
by establishing a robust protocol that minimizes biases and captures a
majority of footprints in the correct reading frame. We harvested and
lysed HEK 293T cells and yeast by rapid cryogenic freezing and
analyzed the effect of different digestion strengths on library quality
by varying RNase I concentration. Since short footprints are sensitive
to CHX treatment in yeast, we did not pre-incubate human or yeast
samples with the translation inhibitor and lysed the cells in a buffer
devoid of the drug.
In human cells a strong RNase I digestion centers footprint-
distribution at around 21 and 30 nt (Supplementary Fig. 1a).
Importantly, 87% and 75% of the short and long footprints,
respectively, were in the correct reading frame in samples treated
with 900 U RNase I (Supplementary Fig. 1a, b). A strong digestion of
human samples provided the additional benefit of decreasing the
amount of rRNA in the libraries (Supplementary Fig. 1c). Interest-
ingly, the amounts of other contaminants upon stronger digestion
remain constant but the identity of contaminating species within
those fraction changes in the short footprints (Supplementary
Fig. 1d). Similar to human cells, yeast samples substantially benefited
from stronger RNase I digestion resulting in a pronounced increase
in the fraction of in-frame reads for 28 nt footprints when using
600–800 U RNase I (Supplementary Fig. 1e, f). Using our protocol,
>60% of the reads uniquely map to the yeast transcriptome without
using rRNA depletion. Therefore, we generated ribosome profiling
libraries from lysates that were treated with high concentrations of
RNase I (900 U for HEK 293T cells and 600 U for yeast).
Cycloheximide differentially affects human and yeast ribo-
somes. CHX induced biases have been reported in ribosome
profiling data from yeast31–36. However, even in yeast, most
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analyses compared datasets that were not generated in parallel,
and no study has systematically investigated the effects of CHX at
the different steps of sample preparation in human cells. Hence,
we directly compared three treatments (Fig. 1a and Supplemen-
tary Fig. 1g): First, we incubated HEK 293T cells for 1 min in a
medium containing CHX prior to lysis and included the drug in
the lysis buffer (+/+). Second, cells were subjected to CHX only
in the lysis buffer (−/+). Finally, we lysed the cells without CHX
pre-incubation in a buffer devoid of the drug (−/−). All
experiments were performed in parallel and cells were lysed
Fig. 1 Cycloheximide (CHX) does not affect ribosome footprint length distribution in HEK 293T cells. a Schematic overview of the harvesting and CHX-
treatment conditions used for HEK 293T cells. CHX treatment conditions in this and all figures are indicated by color: +/+, green; −/+, yellow; −/−, pink.
b Representative histograms showing the influence of CHX on footprint length and reading-frame distribution in HEK 293T libraries. The reading frame in
all figures is indicated by color: 0, purple; 1, green; 2, yellow. c Same as b for HEK 293T cells treated with different CHX concentrations and incubation
period. Footprints were excised between 18 and 32 nt.
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cryogenically in liquid nitrogen to limit ribosome run-off. For
inter-species comparisons, we harvested yeast by rapid filtration
and flash froze the cells using the same three treatment
conditions.
In yeast, CHX stabilizes ribosomes yielding primarily long
footprints. Short footprints mainly occur if no CHX is used or if it
is applied in combination with inhibitors like tigecycline32,37. To
examine whether CHX similarly skews the ribosomal population
towards large footprints in human cells, we isolated RNase-
protected fragments between 18 and 32 nt. Surprisingly, we
observed that human ribosomes contain short footprints
irrespective of CHX treatment (Fig. 1b). To exclude the possibility
that the CHX treatment of HEK 293T cells was too weak to
mediate a shift to long footprints, we increased both incubation
time and drug concentration. However, the short footprints
persisted regardless of the duration or strength of CHX treatment
(Fig. 1c). In agreement with our observation, short footprints can
even be observed in human cells following extended CHX
treatment of up to 24 h38 (Supplementary Fig. 1h–j) or in
combination with tigecycline (Supplementary Fig. 1k–m)37.
Furthermore, we confirmed the published observations in yeast,
where small footprints only occur when CHX is omitted (−/−)
but are barely present if CHX is used in the lysis buffer (−/+ and
+/+) (Supplementary Fig. 1n)32,37. These findings suggest that
regardless of the concentration or duration of the CHX treatment
or the use of translation inhibitor cocktails, human ribosomes do
not completely arrest in only one conformation. These findings
further show that CHX affects ribosome profiling experiments in
human and yeast differently and that the use of CHX in ribosome
profiling has to be assessed for each organism separately.
During the translation elongation cycle, ribosomes adopt several
conformations. Nevertheless, only two distinct footprint sizes can be
isolated in ribosome profiling experiments32,37. Recently, cocktails of
translation inhibitors were introduced to enrich for specific steps of
translation elongation37. In yeast libraries that used inhibitor
cocktails short footprints appear to more accurately reflect
translation than classical long footprints, while this difference is
less striking if only CHX is used37. To assess the situation in human
cells, we analyzed short and long footprints of the published HeLa
datasets37. Interestingly, HeLa cells starved for glutamine show
stronger codon-specific effects in short footprints due to perturbed
charging of tRNAGlnUUG and tRNA
Gln
CUG (Supplementary Fig. 1o, left).
However, the long footprint data showed the same result. While the
scale of the effect was weaker, the data were less noisy for long
footprints (Supplementary Fig. 1o, right). Since the implementation
of ribosome profiling, hundreds of studies have analyzed long
footprints. Furthermore, analyses of codon-specific perturbations by
using tRNA modification mutants have shown that long footprints
provide robust information about translational slowdown8,39–43.
Therefore, we focused our analyses on long footprints and included
short footprints for comparison whenever possible.
Translation ramp and ribosomal occupancy are independent of
CHX. Ribosome profiling data can be used to infer elongation rates
along a transcript, because footprint densities reflect the local resi-
dence times of ribosomes13. Several studies in yeast have described
an increase in ribosome density in the first ~200 codons of ORFs.
This phenomenon is called the “5′ translation ramp” and is thought
to be caused by a low elongation speed in this region7,44,45. In
contrast, a study in murine embryonic stem cells concluded that a
similar ramp does not occur in vertebrate cells5. To elucidate the
effect of CHX on this phenomenon, we analyzed footprint density at
the beginning of the open reading frames. Importantly, we found an
enrichment of ribosomes from 15 to ~150 codons irrespective of
drug treatment and footprint length in human cells (Fig. 2a and
Supplementary Fig. 2a–c). The scale of this effect and the position of
the maximum footprint density differ between human and yeast
(~60 codons in humans, and ~40 codons in yeast; Supplementary
Fig. 2d). However, the ramp is independent of gene-translation levels
and gene length (Supplementary Fig. 2b, c, e). This shows that the
translation ramp itself is not induced by CHX but is a genuine
biological feature of translation in humans as well as in yeast.
Multiple factors were proposed to trigger the translational ramp,
such as the presence of rare codons with low cognate tRNA avail-
ability, mRNA secondary structures, or the interaction of nascent
polypeptides with the ribosomal exit tunnel39,40,46. Our results
exclude that CHX treatment, gene length, or transcript expression
levels are primary contributing factors (Fig. 2 and Supplementary
Fig. 2). However, ribosome density is increased in the first ~15
codons in human and yeast +/+ libraries and to a lesser extent in
the −/+ and −/− libraries (Fig. 2a and Supplementary Fig. 2a, b).
This is consistent with the observation that CHX arrests elongation
but does not block translation initiation at the concentration gen-
erally used in ribosome profiling29. Therefore, we do not recom-
mend to pre-treat cultures with CHX. In case that an experiment
requires CHX pre-incubation, time should be kept to a minimum.
Furthermore, the first codons should be excluded from gene-
expression analyses since this accumulation will skew the analysis of
differential gene translation towards initiation rates and does not
reflect global gene translation levels.
Our analysis of the translation ramp suggested, that CHX does
not induce a global effect on ribosome coverage in human cells.
To similarly confirm this at the level of gene expression, we
counted uniquely mapped ribosome footprints across the human
transcriptome and determined differential abundance between
+/+, −/+, and −/− libraries using DESeq2 (Fig. 2b and
Supplementary Data 1)47. We observed very few transcripts (<24
out of 12,330 analyzed) that were significantly altered by CHX
treatment (Fig. 2b; blue dots). The absence of deviations in
ribosome occupancy upon CHX treatment was not caused by
technical variability of the sequencing libraries since many
transcripts were unaffected (long footprints, 46–48%) with
statistical certainty (Fig. 2b; top right; red dots). For short
footprints, only 14% of the transcripts are unaffected with
statistical certainty due to the low read count for many genes and
strict filtering of genes with low counts during differential
expression analysis with DESeq2 (Fig. 2b; bottom left; red dots).
Thus, human cells do not display altered ribosome occupancy at
the transcript level upon CHX treatment, and translation levels
can be compared irrespective of CHX use.
Next, we analyzed footprint density around the annotated start
and stop codons. The enrichment of reads at the initiation site in
response to CHX pre-treatment can be exploited to identify
upstream open reading frames (uORFs) or other features that are
associated with initiation. Recently, it was reported that
translation initiation at non-AUG start codons encoding for
uORFs or N-terminal protein extensions is resistant to CHX
treatment38. Therefore, we tested whether the different treatment
conditions influence ribosome occupancy in the 5′ untranslated
region (UTR) and compared the reads mapping to the region
upstream of annotated AUG start codons. Using long footprints,
we found 317 upregulated and 257 downregulated 5′ UTRs in the
+/+ condition compared to −/+ (Supplementary Fig. 2f). In
contrast, comparing −/− and -/+ libraries revealed only 7
downregulated UTRs. For short footprints, the low number of
UTR reads did not allow for a meaningful comparison. Thus,
CHX pre-treatment alters the footprint density in the 5′ UTR and
might be an interesting strategy to complement drugs like
harringtonine or lactimidomycin for uORF identification5,20.
Finally, we observed an accumulation of ribosomal footprints
at stop codons in all three conditions, but most prominently in
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Fig. 2 Cycloheximide (CHX) does not affect the translation ramp or global translation levels. a Normalized ribosomal A-site coverage observed in long
footprints (29–31 nt) for the first 200 (left) and last 200 (right) codons in HEK 293T cells in highly expressed genes (>64 reads). The solid line depicts the mean
and shaded areas represent 95% confidence intervals for three biological replicates (n= 3). b Differential ribosome occupancy of open reading frames (ORFs) in
HEK 293T cells across inhibitor treatments were identified using DESeq2, which uses a negative binomial distribution model with fitted mean47. Uniquely mapped
reads were split into short footprints (bottom left; 21–22 nt) and long footprints (top right; 28–32 nt). ORFs, after excluding the first 15 codons, were tested for
differential translation (adjusted p-value≤0.05) and for unaltered translation (adjusted p-value≤0.05). Significantly altered ORFs are indicated in blue, unaltered
transcripts in red.
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the −/+ libraries (Fig. 2a and Supplementary Fig. 2a, d),
consistent with reports in murine and yeast cells5,33,45. This
emphasizes that the steps during translation termination differ
from normal translation elongation and is consistent with the
observation that termination complexes are differentially stabi-
lized by the addition of CHX48. It is possible that ribosome
splitting is affected by CHX and does not occur in the −/+
extracts while it can still occur in untreated −/− samples. While
it is yet unclear, which of the three treatment options captures the
in vivo situation at the stop codon most realistically, this effect
can likely be exploited to complement in vitro termination
experiments.
Cycloheximide does not affect A-site codon-level ribosome
occupancy in human cells. CHX arrests translation by binding to
the ribosomal E-site thereby locking ribosomes in the pre-
translocation state37. However, CHX-binding kinetics might dif-
fer for specific codons present in the ribosomal sites leading to
their mis-representation as described for CGA and—albeit
weaker—CGG in yeast33. This would be perceived as an alteration
in the decoding kinetics of specific codons but may remain
undetected when quantifying occupancy across transcripts con-
sisting of hundreds of codons. To test for the CHX-dependent
enrichment of codons, we calculated transcriptome-wide codon
occupancy for the A-, P-, and E-site codons in human and yeast
(Fig. 3a–c and Supplementary Fig. 3a). For short and long foot-
prints, correlations of A-site-codon occupancy in HEK 293T
libraries were very high, independent of the treatment (R2 ≥ 0.92
between all conditions; Fig. 3a). Similarly, P-site-codon occu-
pancy correlated well between treatments (R2 ≥ 0.74; Fig. 3b)
while CHX pre-treatment changed E-site-codon occupancy
markedly (R2= 0.28–0.35 for +/+ and −/− conditions; Fig. 3c).
A-site codon occupancy in human cells was not strongly affected
by the digestion strength during footprint generation (Supple-
mentary Fig. 3b). Similarly, the duration of CHX incubation or
the use of a different cell line (HeLa instead of HEK 293T) only
played a minor role (Supplementary Fig. 3c). This shows that
codon-specific analyses except for the E-site can be conducted in
human cells independent of CHX treatment. In contrast to
human cells, pre-incubation with CHX was the key factor that
affected A-site-codon correlations between yeast samples (R2
+/+ vs. −/+ = 0.04 and R2 +/+ vs. −/− = 0.15; Supplementary
Fig. 3a), while the addition of the inhibitor to the lysis buffer had
a low impact on A-site-codon occupancy (R2 −/− vs. −/+ =
0.86; Supplementary Fig. 3d). This further emphasizes that the
use of CHX in ribosome profiling needs to be viewed in a species-
specific manner and that its use in human cells does not distort
the data even at the codon level when applied carefully.
To estimate the influence of CHX at the codon level in yeast,
we compared A-site-codon occupancy in a large number of
libraries that used different CHX-treatment conditions in wild-
type yeast8,31,32,49–51. It is striking that +/+ experiments
correlate well between laboratories, but not with −/+ or −/−
(Supplementary Fig. 3d). However, it is difficult to assess which
type of treatment reflects the in vivo situation best. To address
this question, we analyzed 5′P sequencing (5PSeq) and translation
complex profile (TCP) sequencing libraries, which use orthogonal
strategies to determine ribosomal positions across the
transcriptome52,53. 5PSeq analyses exonucleolytically degraded
5′-monophosphorylated mRNA intermediates, thereby determin-
ing the position of the 5′-most ribosome on a mRNA that
undergoes degradation52. TCP-seq uses formaldehyde fixation of
living cells in the absence of CHX prior to the generation of
ribosome profiling libraries allowing the identification of
ribosomal complexes that undergo scanning and initiation53.
Interestingly, results of TCP-seq correlate well with −/+ and
−/− libraries (R2 −/+ vs. TCP-seq = 0.69; R2 −/− vs. TCP-seq
= 0.50), but not with +/+ libraries (R2 +/+ vs. TCP-
seq=−0.21; Supplementary Fig. 3e, f). Similarly, 5PSeq corre-
lates more with the libraries that do not use CHX pre-incubation
(Supplementary Fig. 3e, f). In summary, the analyses of TCP-seq
and 5PSeq support the idea that the pre-incubation with CHX is
the critical difference between libraries and that samples without
pre-incubation are most suitable to represent the in vivo situation
in baker’s yeast.
The absence of CHX-dependent ribosomal waves is consistent
across most species. One of the main reasons behind contra-
dictory translation rates of specific codons in yeast was the
observation of increased ribosome occupancy downstream of
specific codons in CHX-treated samples33. These ribosomal
“waves” occur downstream of the rare CGA and CGG codons.
CGG is decoded by the essential tRNAArgCCG, which is expressed
from a single gene in baker’s yeast54,55. CGA exhibits a more
pronounced wave than CGG and is read by tRNAArgICG requiring a
wobble interaction to be decoded33,56. As expected, we observed a
wave for CGA and CGG in the +/+ but not in the −/+ and −/−
libraries in yeast (Fig. 4a). However, we did not observe a similar
effect for CGA in HEK 293T cells (Fig. 4b and Supplementary
Fig. 4). In humans, decoding of CGA relies on its cognate
tRNAArgUCG and does not require wobble interactions
54,55. Fur-
thermore, there are no codons in humans that are decoded by a
single tRNA like tRNAArgCCG in yeast (Supplementary Table 1).
Consistently, we did not observe wave formation for any codon in
humans. Even for the UUA codon that is both rare and has a low
tRNA copy number in humans, we did not detect CHX-induced
downstream enrichment of ribosomes (Fig. 4b and Supplemen-
tary Fig. 4). These ribosomal waves are not only absent from our
human-cell libraries, but from all published human ribosome
profiling datasets that we analyzed (Fig. 4c). Interestingly, this
effect is not specific to human cells, because ribosomal waves are
absent from ribosome profiling data of other vertebrates (Fig. 4a).
Neither zebrafish10 nor mouse5 show ribosome enrichment
downstream of any codon. Finally, to investigate whether altered
translation at rare codons is a general feature of yeasts, we gen-
erated ribosome profiling libraries from CHX-treated Schizo-
saccharomyces pombe and Candida albicans. Like in S. cerevisiae,
CGG is decoded by a single copy of tRNAArgCCG in both species.
However, while CGA is decoded by its cognate tRNAArgUCG in S.
pombe, it depends on decoding by tRNAArgICG in C. albicans. Sur-
prisingly, we did not observe ribosomal waves at CGA, CGG or
any other codon in both yeasts (Fig. 4d). This shows that ribo-
somal waves are specific to baker’s yeast and that the use of CHX
is, therefore, mainly a concern when studying translation in S.
cerevisiae, but not in other widely used eukaryotic model
organisms.
Variability in library preparation or culture conditions may
contribute to the poor correlation between similar samples. We
found that the impact of cycloheximide depends on the model
organism. Furthermore, the use of CHX in the lysis buffer did not
affect the correlation of A- and P-site codons in human cells.
Therefore, we analyzed how much variability exists between ribo-
some profiling datasets generated by different laboratories. Surpris-
ingly, ribosome profiling data from different laboratories differed
substantially, independent of whether HEK 293 or HEK 293T cells
were used (Fig. 5a). This is less striking for yeast samples, where the
difference between datasets is mainly explained by CHX pre-
incubation (Supplementary Fig. 3d). When comparing the protocols
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Fig. 3 Cycloheximide (CHX) does not alter mammalian ribosome occupancy at the A-site and the P-site. a Correlation analysis of transcriptome-wide A-
site codon occupancy in HEK 293T cells across different CHX treatments for short and long footprints. The solid line depicts the fitted line and shaded
areas represent 95% confidence intervals for three biological replicates (n= 3). Each black dot represents a codon. The size of the box indicates p-values.
Correlations with a p-value > 0.05 are crossed out. b Like a for P-site codon occupancy. c Like a for E-site codon occupancy. Footprints were excised
between 18 and 32 nt but are represented according to size: short footprints (21–22 nt) and long footprints (29–31 nt).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-25411-y ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:5094 | https://doi.org/10.1038/s41467-021-25411-y | www.nature.com/naturecommunications 7
carefully, we found a large variability in cell harvesting, gradient
centrifugation, the amount of cell lysate used for digestion, RNase I
digestion temperature, digestion time, and the library-preparation
methods (Supplementary Table 2). Furthermore, passage number,
the time between feeding cells, and harvesting or media age were
factors that we were unable to assess. These seemingly minor details
are often overlooked when comparing ribosome profiling experi-
ments but appear to have profound effects on library characteristics
(Supplementary Fig. 5a, b). We excluded that either the strength of
digestion, the cell line, or CHX incubation time are key factors that
can individually explain the observed differences in A-site codon
occupancy (Supplementary Fig. 3b, c). Furthermore, we analyzed the
genetic diversity of the cells based on differences in single-nucleotide
polymorphisms (SNPs). However, we did not find evidence that the
cells differed significantly. Therefore, our analysis suggests that a
combination of factors causes these differences and that the influ-
ence of these steps in the protocol is more relevant than generally
thought. In human cells, these subtle differences can outweigh the
Fig. 4 Cycloheximide (CHX) pre-treatment does not alter ribosome occupancy downstream of rare codons in most species. a Transcriptome-wide
ribosome enrichment profiles according to Hussmann et al. 33 using libraries generated from E14 mouse embryonic stem cells5, zebrafish embryos10, and
wild-type yeast (this study) surrounding CGA and UUA codons and using different CHX treatment regimens. b Same as a for long footprints of HEK
293T cells. c Same as a for published human ribosome profiling datasets19, 20, 58–63. d Same as a for the CGA codon in C. albicans and S. pombe (this study).
This plot only uses long footprints (28–32 nt).
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effects of CHX treatment since libraries prepared by the same
laboratory often correlate better despite inhibitor use when com-
pared to samples from different laboratories using the same
experimental regimen.
Discussion
Since its implementation more than a decade ago ribosome
profiling has undergone continuous adaptations and improve-
ments. Even though some aspects of the protocol—like the
treatment with CHX—have been the focus of intense discussions,
other aspects have received less attention. We found that stronger
nuclease digestion improves reading-frame information and
narrows read-length distribution in both human and yeast. Fur-
thermore, this strategy reduced rRNA contamination (Supple-
mentary Fig. 1c) and enhanced data quality allowing us to better
investigate the effect of CHX. To further reduce library con-
taminations, it might be beneficial to compare cocktails of
nucleases and to optimize the RNA-to-RNase ratio24. However,
nucleases need to be titrated for each cell line as different cell
types contain different amounts of RNase inhibitors57.
The use of CHX in ribosome profiling has been challenged by
reports about CHX-induced biases in baker’s yeast31–36. This may
have even prompted researchers to repeat experiments without
the inhibitor to confirm previous findings leading to a duplication
of efforts. Therefore, we have conducted a systematic analysis to
determine the impact of CHX at the different stages of library
preparation in human cells and yeast in parallel experiments.
Importantly, we find that the effect of CHX depends on the
species. Human ribosome profiling libraries generated by rapid
lysis and without prolonged pre-incubation with CHX are devoid
of reported CHX-mediated biases. We did not find significant
differences in global translation levels, the translational ramp or
codon enrichment, findings that we verified by analyzing pub-
lished datasets19,20,58–63.
A codon-specific alteration of ribosome occupancy leading to
ribosomal waves is observed for CGA and CGG in CHX pre-treated
baker’s yeast33. These codons, which are rare in S. cerevisiae, S.
Fig. 5 Cycloheximide (CHX) does not explain the poor correlation between various datasets in humans. Correlation analysis of transcriptome-wide A-
site codon occupancy across data from this study and published datasets for human cells (HEK 293 and HEK 293T cells) using different CHX
treatments19, 20, 58–63. The solid line depicts the fitted line and shaded areas represent 95% confidence intervals for three biological replicates (n= 3). Each
black dot represents a codon. The size of the box indicates p-value. Correlations with a p-value > 0.05 are crossed out.
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pombe, and C. albicans, exhibit either low levels of cognate tRNA or
depend on wobble decoding56. Hence, their tRNA adaptation index
(tAI) values, a measure of codon-anticodon decoding that takes into
account tRNA copy numbers and wobble-pairing constraints64, are
very low. In vertebrates, CGA is not a rare codon and its tAI values
and elongation rate are intermediate. Furthermore, in common
vertebrate models, no codon features a similarly low codon frequency
and depends on wobble decoding like CGA in yeast, suggesting that
these organisms are less likely to be affected by CHX treatment.
Consistently, we found no evidence of ribosome enrichment down-
stream of any codon in zebrafish, mice, and humans. It would require
more replicates and deeper sequencing to detect subtle effects in
specific ORFs or for specific codon pairs. In baker’s yeast, the inef-
ficient decoding of CGA largely depends on wobble pairing to
tRNAArgICG with a minor contribution of tRNA abundance
56. However,
neither low codon frequency, low tRNA copy numbers nor wobble
codon-anticodon interactions can explain CHX-mediated waves as
single factors as shown by the comparison with S. pombe and C.
albicans (Fig. 4d). It cannot be excluded that differences in elongation
rate or a rate-limiting elongation step that varies between yeast and
mammals lead to the observed differences. However, the comparison
to S. pombe and C. albicans makes this less likely. Baker’s yeast may
vary from other species by its uptake and turnover of CHX or by
subtle structural features of the yeast ribosome and how CHX
interacts with it. We excluded slower uptake of CHX in human cells
as a contributing factor by increasing CHX concentrations and
incubation time (Fig. 1c). A recent study reported that the binding
site of CHX in human ribosomes is similar to yeast, but that the
ligand adopts a different conformation65. This might facilitate a more
stable binding of CHX to human ribosomes leading to a better
preservation of their position on mRNA. Interestingly, a rpl1bΔ
mutant was shown to improve translation of CGA codons pointing
towards structural constraints of yeast ribosomes66. Therefore, special
care will be required when analyzing CGA. However, this codon
similarly triggers phenotypes in orthogonal assays56,67,68. Hence, the
observed effects likely indicate a true biological feature. To disen-
tangle the molecular mechanisms will necessitate a detailed analysis
of CHX-binding to ribosomes in more organisms.
But which CHX treatment should be used for ribosome pro-
filing? In human cells, we did not observe global differences in
ribosome occupancy between the treatments. Furthermore, A-site
and P-site occupancy are not altered (Fig. 3a, b). To clarify the
situation in S. cerevisiae, we used data from 5PSeq and TCP-seq
to identify the regimen of CHX usage that best matches the
in vivo situation. The results speak against CHX pre-treatment
(Supplementary Fig. 3e, f). However, the small number of pub-
lished TCP-seq and 5PSeq libraries did not allow us to distinguish
between the −/+ and the −/− conditions. More independent
experiments will be required to reach a final conclusion. Inter-
estingly, the two 5PSeq libraries correlated most strongly with
each other independent of CHX use (Supplementary Fig. 3e),
suggesting that the characterization of the last translating ribo-
some during mRNA degradation is influenced by factors like the
processivity of the degradation machinery in addition to trans-
lation dynamics. Therefore, 5PSeq may not be optimal to assess
the influence of CHX on ribosome profiling. We conclude that
using CHX in the lysis buffer without pre-treatment of the culture
has only a minor influence on ribosomal A-site-codon occupancy
even in yeast. Therefore, we generally recommend the use of the
−/+ protocol for human cells and other species including yeast.
Adding CHX to the lysis buffer provides the advantage of limiting
ribosomal run-off. If the experimental design requires CHX pre-
incubation, the exposure of the cells should be kept as brief as
possible (≤1 min) to avoid an accumulation of reads around the
start unless this is intended.
We performed our experiments under rich-media conditions
in cells that were not exposed to stress during culture and har-
vesting. We cannot exclude that CHX-mediated effects occur
under specific stress and in certain species. The step that appears
most vulnerable is initiation (Fig. 2a and Supplementary
Fig. 2a–e). However, stresses that affect translation initiation will
very likely coincide with a general stress response that will be
visible in the gene-expression pattern (e.g., by induction of GCN4
in yeast)39,69. In particular, in light of reports that found changes
in translation efficiency in response to starvation upon long pre-
treatment with CHX, it is advisable to verify findings by omitting
CHX from experiments36. However, at this point, there is no
evidence of the negative effects of using CHX in the buffer (−/+).
There are three conditions that require specific attention when
using cycloheximide: first, E-site codon occupancy is affected by
pre-treatment with CHX in human cells. Generally, the E-site is
not considered critical for decoding or peptide-bond formation.
However, for researchers interested in E-site biology, the use of
CHX is not recommended. Since CHX binds to the E-site its
presence likely alters the E-site interaction with tRNA thus
affecting tRNA release. Second, CHX blocks elongation but not
initiation. This leads to an enrichment of reads around the
initiation site as a function of the initiation rate and the extent of
CHX treatment. While this effect can be used intentionally to
enrich for initiation sites in species where harringtonine and
lactimidomycin do not work, it is generally advised to exclude the
first few codons of a gene from most analyses. Third, termination
differs from normal elongation cycles. Ribosomes spend more
time at stop codons, which is apparent in all treatment condi-
tions. However, the strongest enrichment is seen in −/+ libraries.
Ribosomes are likely able to enter the termination cycle but fail to
terminate since CHX in the lysis buffer locks the ribosomes in the
unrotated state thereby stabilizing termination complexes48. To
specifically analyze termination, it might be beneficial to use the
different treatments side by side.
Recently, short footprints have been used as a tool to obtain
more information about ribosomal conformations in addition to
the canonical long footprints32,37. In yeast, short footprints show
a high anti-correlation with the tAI. However, no significant
correlation with 1/tAI is seen in human cells (Supplementary
Fig. 5c). Similarly, the correlation between codon occupancy and
amino acid polarity observed for short footprints in yeast32 is
absent in human cells (Supplementary Fig. 5d). In fact, we did not
find a significant correlation between codon occupancy and most
of the biochemical properties of amino acids for both long and
short footprints (Supplementary Fig. 5d). Short footprints either
derive from rotated ribosomes or from unrotated pre-
accommodation-state ribosomes with an empty A-site32,37. In
libraries that are devoid of CHX short and long footprints
simultaneously occur in yeast32, while both types of footprints are
present in human libraries independent of the CHX regimen
(Fig. 1b and Supplementary Fig. 1h–m). While empty A-sites can
be induced by treatments like specific amino acid starvation or
the use of tRNA toxins37, it is difficult to distinguish these two
types of short footprints in vivo. By combining CHX with other
inhibitors like tigecycline or anisomycin in yeast specific types of
short footprints can be enriched, allowing to further improve the
resolution of ribosome profiling37. Nevertheless, the use of
canonical long footprints and CHX have allowed to identify
biologically meaningful features in ribosome profiling experi-
ments, e.g., in the analysis of tRNA modification
mutants8,39–41,43. We have analyzed several features in ribosome
profiling data in response to CHX exposure independently for
small and large footprints and found the results to be very similar.
Even though subtle differences may exist, these appear to be
rather of quantitative than qualitative nature. Currently, it is
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unclear whether the simultaneous purification of both footprints
sizes increases the information gain in cases when inhibitor
cocktails are not used. The recovery of short and long footprints
requires a wide size selection from the acrylamide gel, thereby
increasing the contamination with rRNA. Since the quality of the
results correlates with the amount of usable data an increase in
contamination is a factor that needs to be carefully balanced.
Thus, unless the research question necessitates the preparation of
small footprints, e.g., when empty A-sites are expected, the use of
large footprints appears fully justified. This strategy has the added
advantage of being able to compare the data to hundreds of
published datasets that have used long footprints. Nevertheless,
the use of inhibitor cocktails has provided us with new strategies
to further probe translation dynamics.
CHX-induced effects have drawn a lot of attention. However, the
contribution of other factors has likely been underestimated. While
analyzing ribosome profiling data from various studies, we observed
discrepancies in library properties such as fragment length, the
extent of frame information, and the level of contamination by
rRNA or small RNAs (Supplementary Fig. 5a and b). Such differ-
ences likely stem from laboratory-specific procedures during, e.g.,
cell handling, lysis, digestion, or size selection. However, these effects
may affect the analysis of translation dynamics more than the use of
CHX (Fig. 5) or even the use of different cell lines (Supplementary
Fig. 3c). And similar to the use of CHX such effects can be species-
specific. For instance, rapid filtration and flash-freezing leads to
minimal biases in yeast and have become the gold standard, because
harvesting by centrifugation elicits an immediate starvation
response70. However, the same strategy induces pauses at serine and
glycine codons in the A-site of E. coli71.
To ensure meaningful analyses it will be critical to be as
transparent as possible about experimental conditions. Since it is
difficult to identify the sources of variability, we urge the com-
munity to standardize the ribosome profiling protocol and to set
clear standards for reporting how libraries are prepared. This
includes (I) the duration and exact use of inhibitors, (II) the
method of lysis, (III) the concentration of nucleases relative to the
amount of nucleic acids, (IV) the duration and temperature of
footprinting, and (V) which footprint sizes were selected for
library preparation and whether they were pooled or not.
Knowing these details for individual experiments will allow the
community to select, which published datasets and translational
features can be directly compared.
Methods
A detailed ribosome profiling protocol is provided in the Supplementary Methods.
Yeast harvesting and footprinting. Overnight cultures of wild-type yeasts in the
BY4741 (S. cerevisiae), 972(h−) (S. pombe), and SN87 (C. albicans) backgrounds
were diluted and grown to mid-exponential phase (OD600 ~ 0.4). For +/+ samples,
CHX was added to a total concentration of 100 µg/ml, and cultures were gently
agitated for 1 min at 30 °C. Cells were rapidly harvested by vacuum filtration
through a 0.45 µm cellulose nitrate filter (GE Healthcare) and immediately flash-
frozen. Samples were mechanically lysed under cryogenic conditions in a Freezer-
Mill (SPEX SamplePrep) with 2 cycles at 5 CPS interspersed by 2 min of cooling.
Lysates were thawed in lysis buffer (20 mM Tris-HCl pH 7.4, 5 mM MgCl2,
100 mM NaCl, 1% Triton, 2 mM DTT) containing 100 µg/ml CHX for +/+ and
−/+ samples and clarified by two rounds of centrifugation (5 min; 4 °C; 10,000×g).
Unless specified otherwise, 10 A260 units of cleared lysates were digested with 600
U Ambion RNase I (ThermoFisher) for 1 h at 22 °C and the reaction was inhibited
by the addition of 15 µl SuperaseIn (ThermoFisher). Monosomes were isolated
from the sucrose gradients according to ref. 8. All libraries were prepared from
footprints in the range of 18–32 nt (HEK 293T) and 18–30 nt (S. cerevisiae). These
footprints were cut from acrylamide gels using RNA size markers of 18 nt and 30
nt (yeast) or 18 nt and 32 nt (HEK 293T). Finally, libraries were generated using 3′-
adapters that were randomized at the first 4 positions of the 5′ end to minimize
potential ligation biases19,22. A detailed protocol can be accessed in supplementary
methods.
HEK 293T cell harvesting and footprinting. For the +/+ samples, cultured HEK
293T cells were incubated with a medium containing 100 µg/ml CHX for 1 min,
washed with ice-cold PBS, and flash-frozen in liquid nitrogen. The dish was swiftly
transferred to ice and 400 µl lysis buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl,
5 mM MgCl2, 1% Triton X-100, 0.5 mM DTT, 0.5% deoxycholate (w/v) and
100 µg/ml CHX) was dripped onto the cells. The cells were harvested on ice by
scraping once the lysis buffer was thawed. Cells for −/+ and −/− conditions were
harvested like +/+, however, CHX pre-incubation was omitted and it was not
added to the lysis buffer for −/−. Samples were clarified by centrifugation (5 min;
4 °C; 10,000×g). Unless specified otherwise, 10 A260 units of cleared lysates were
digested with 900 U RNase I (ThermoFisher) for 1 h at 22 °C and the reaction was
inhibited by the addition of 15 µl SuperaseIn (ThermoFisher). Monosomes were
isolated from the sucrose gradients and libraries were prepared analogous to yeast
samples.
Sequencing, processing, and mapping of reads. Ribosome profiling and RNA-Seq
libraries were sequenced on Illumina HiScanSQ and NextSeq sequencers. Ribosome
profiling reads were processed by clipping the adapter sequence and trimming the 4
randomized nucleotides of the linker using the FASTX-Toolkit (http://
hannonlab.cshl.edu/fastx_toolkit, June 2017), version 0.0.13. Processed yeast reads
were mapped to tRNA, rRNA, snRNA, and snoRNA genes from SGD to remove
possible contaminants using bowtie72 version 1.0.0. Processed reads from human
samples were mapped to rRNA using bowtie version 1.2.1.1. Residual reads were
uniquely mapped to non-dubious ORFs (sgdGene) using bowtie. Reference ORFs
(hg38 UCSC canonical transcripts; mm10 UCSC genes; danRer10; C_albi-
cans_SC5314_version_A22; Pombe_ASM294v2) were extended by 18 nt into the
UTRs to allow alignment of footprints from initiating and terminating ribosomes.
The majority of mapped footprints had a length of 29–31 nt, 30–32 nt, and
27–29 nt in human, mouse, and yeast, respectively. We assigned these mapped
footprints to A-site codons according to the frame of the 5′ end of footprints4. For
footprints with the 5′ end in the −1 frame the A-site was defined as position 17–19
and the ones with 5′ ends in the 0 frame as position 16–18.
For ribosome occupancy at the beginning of ORFs, we normalized the coverage





Where Fij and Dij are the ribosome footprints and density of position j of gene i,
respectively. Li is the length of genes in codons. The average of ribosome densities
at the position j is calculated by normalizing to the number of all well-expressed





Where Aj is the average of ribosome densities and N is the number of genes.
A-site codon occupancy plots8 and wave plots33 were generated as described.
Differential gene-expression analysis was performed using the DESeq2 package47.
Count matrix for long and short footprints was generated using a custom script
that excluded the first 15 codons of a transcript. For altered transcripts, the padj
threshold (alpha) was set to 0.05. To identify unaltered transcripts, the
althypothesis function was set to “lessAbs”. Correlation plots were generated using
corrplot package73.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data that support this study are available from the corresponding author upon
reasonable request. The sequencing data from the ribosome profiling experiments used in
this study are available in the Gene Expression Omnibus database under accession code
GSE136940.
Code availability
The description of the algorithms applied are found in the methods section. Source codes
for codon-occupancy calculations are available on github (https://github.com/LeidelLab/
Codon_occupancy_cal).
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